VYNE Therapeutics Inc.VYNE Therapeutics Inc.VYNE Therapeutics Inc.

VYNE Therapeutics Inc.

No trades
See on Supercharts

Price target

5.580.00 0.00%
The 3 analysts offering 1 year price forecasts for VYNE have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to VYNE in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

VYNE EPS for the last quarter is −0.18 USD despite the estimation of −0.50 USD. In the next quarter EPS is expected to reach −0.24 USD. Track more of VYNE Therapeutics Inc. financials and stay on top of what is up with the company.
In the next quarter VYNE Therapeutics Inc. revenue is expected to reach ‪100.00 K‬ USD. Check out VYNE Therapeutics Inc. revenue and earnings and make informed decisions.
According to analysts, VYNE price target is 5.58 USD with a max estimate of 6.00 USD and a min estimate of 5.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with VYNE news and stock market news.